update on tirzepatide lawsuit Eli Lilly sues Mochi Health and others for 'deceptive' marketing Oral Tirzepatide Class Action Lawsuit

The investigators demonstrated an increased growth and progression of PanIN lesions compared to animals without CP at baseline 18

And it deserves the attention

PBMs like CVS Caremark are feeling the pressure to either restrict access or strike better pricing deals with manufacturers

The Future of Diabetes Treatment with Compounded Tirzepatide As more research is conducted and evidence of its effectiveness accumulates, compounded Tirzepatide emerges as a promising future of diabetes treatment

See more...

Compounded tirzepatide from licensed 503A pharmacies carries specific stability data from the compounding pharmacy, and deviations from recommended temperature ranges can alter the milligram-per-milliliter concentration you're actually receiving with each injection